A drug already sold in Europe hampers the relentless assault of late-stage Alzheimer’s disease, a new study reveals. The finding suggests that the drug, called memantine, could help patients previously considered untreatable.
“This is really the first drug that seems to have had salutary effects in the more advanced cases of Alzheimer’s disease,” says Neil S.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.